Updated

A large health-record analysis found that people taking glucosamine, a popular joint supplement, were 25% more likely to progress from mild cognitive impairment to dementia. Lab experiments suggest glucosamine may worsen an abnormal sugar-tagging process implicated in Alzheimer's disease. Researchers caution that clinical trials are needed to confirm causation, but the findings raise concern given the supplement's widespread use among older adults.